Key result
Each additional abnormal noninvasive risk stratification test significantly increased the risk of first appropriate ICD shock (HR 1.793; 95% CI 1.255-2.564) and total mortality (HR 5.069).
Why the study?
Does combining noninvasive risk stratification parameters improve the prediction of mortality and appropriate ICD shocks in patients implanted with an ICD?
Cohort (n=220)
Does combining noninvasive risk stratification parameters improve the prediction of mortality and appropriate ICD shocks in patients implanted with an ICD?
Hazard Ratio: 1.793 (95% CI 1.255–2.564)
Combining noninvasive risk stratification parameters reflecting autonomic function, myocardial substrate, and vulnerability improves the prediction of mortality and appropriate shocks in ICD patients.
May improve SCD risk stratification in ICD patients via combined noninvasive markers; hypothesis-generating, needs prospective validation.
BACKGROUND: Sudden cardiac death (SCD) results from a complex interplay of abnormalities in autonomic function, myocardial substrate and vulnerability. We studied whether a combination of noninvasive risk stratification tests reflecting these key players could improve risk stratification. METHODS: Patients implanted with an ICD in whom 24-hr holter recordings were available prior to implant were included. QRS fragmentation (fQRS) was selected as measure of myocardial substrate and a high ventricular premature beat count (VPB >10/hr) for arrhythmic vulnerability. From receiver operating characteristics analysis, detrended fluctuation analysis (DFA), turbulence slope, and deceleration capacity were selected for autonomic function. Adjusted Cox regression analysis with comparison of C-statistics was performed to predict first appropriate shock (AS) and total mortality. RESULTS: A total of 220 patients were included in the analysis with an overall follow-up of 4.3 ± 3.1 years. A model including VPB >10/hr, inferior fQRS, and abnormal nonedited DFA was the best for prediction of AS after 1 year of follow-up with a trends toward improvement of the C-statistics compared to baseline (p = 0.055). The risk increased significantly with every abnormal test (HR 1.793, 95%CI 1.255-2.564). A model including fQRS in any region and abnormal edited DFA was the best for prediction of mortality after 3 years of follow-up with significant improvement of the C-statistics (p = 0.023). Each abnormal test was associated with a significant increase in mortality (HR 5.069, 95%CI 1.978-12.994). CONCLUSION: Combining noninvasive risk stratification tests according to their physiological background can improve the risk prediction of SCD and mortality.
No takes yet. Share an insight, caveat, or question.
Vandenberk et al. (2018) conducted a cohort in Patients implanted with an ICD (n=220). Abnormal noninvasive risk stratification tests (fQRS, VPB >10/hr, abnormal DFA) vs. Fewer abnormal tests was evaluated on First appropriate shock (AS) (HR 1.793, 95% CI 1.255-2.564). Each additional abnormal noninvasive risk stratification test significantly increased the risk of first appropriate ICD shock (HR 1.793; 95% CI 1.255-2.564) and total mortality (HR 5.069).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: